https://orcid.org/0000-0002-7245-3784
References
- Phillips DR, Scarborough RM. Clinical pharmacology of eptifibatide. Am J Cardiol. 1997;80(4A):11B–20B. Available from: https://pubmed.ncbi.nlm.nih.gov/9291241/
- Khurana D, Deoke SA. Thrombocytopenia in critically ill patients: clinical and laboratorial behavior and its correlation with short-term outcome during hospitalization. Indian J Crit Care Med. 2017;21(12):861–864. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752797/
- Elgohary TS, Zaghla HE, Azab AM, et al. Role of thrombocytopenia as an independent prognostic marker in the critically ill patients with multiorganfailure. Med J Cairo Univ. 2011;79. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752797/
- Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017;129(21):2864–2872. Available from: https://ashpublications.org/blood/article/129/21/2864/36268/Heparin-induced-thrombocytopenia
- Zakarija A, Kwaan HC, Moake JL, et al. Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl. 2009;75(112):S20–4. Available from: https://pubmed.ncbi.nlm.nih.gov/19180126/
- Guo YL, Li JJ, Yuan JQ, et al. Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol. 2010;2(6):160–162. Available from: https://pubmed.ncbi.nlm.nih.gov/21160734/
- Taylor F, Toh C, Hoots K, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330.
- Investigators, P. G. I. I. i. U. A. R. S. U. I. T. P. T. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339(7):436–443. Available from: https://pubmed.ncbi.nlm.nih.gov/9705684/
- Greinacher A, Fuerll B, Zinke H, et al. Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia. Blood. 2009;114(6):1250–1253. Available from: https://pubmed.ncbi.nlm.nih.gov/19429867/
- Bougie DW, Wilker PR, Wuitschick ED, et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa. Blood. 2002;100(6):2071–2076. Available from: https://pubmed.ncbi.nlm.nih.gov/12200368/